Dr. Ravendhran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Geipe Rd
Ste 230
Catonsville, MD 21228Phone+1 410-247-7500Fax+1 410-247-4227
Education & Training
University of Missouri-ColumbiaFellowship, Gastroenterology, 1980 - 1982
University of Miami/Jackson Health SystemFellowship, Gastroenterology, 1979 - 1980
St Agnes HealthCareResidency, Internal Medicine, 1977 - 1979- Church Hospital CorporationInternship, Internal Medicine, 1975 - 1976
Stanley Medical College SMCClass of 1974
Certifications & Licensure
MD State Medical License 1976 - 2025
FL State Medical License 1979 - 1981- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- healing hand soceity Ascencion health services, 2019
- Fellow (AGAF) American Gastroenterological Association, 2007
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection Start of enrollment: 2014 Dec 09
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
- Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects Start of enrollment: 2017 Apr 20
Publications & Presentations
PubMed
- 216 citationsPeginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trialIra M. Jacobson, Robert S. Brown, B. Freilich, Nezam H. Afdhal, P. Kwo
Hepatology. 2007-10-01 - 388 citationsSofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infectionMarc Bourlière, Stuart C. Gordon, Steven L. Flamm, Curtis Cooper, Alnoor Ramji
The New England Journal of Medicine. 2017-05-31 - 20 citationsOn-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvirKris V. Kowdley, David R. Nelson, Jacob Lalezari, Terry Box, Norman Gitlin
Liver International. 2016-11-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
